Eli Lilly issues stronger Zyprexa warning labels

10/7/2007 | NYTimes.com

Labels of the schizophrenia drug Zyprexa now have warnings of the drug's proven side effects, including high blood sugar, weight gain, high cholesterol and other metabolic problems. Eli Lilly and Co. issued the new warning labels Friday, acknowledging that the best-selling drug causes such side effects more than other atypical antipsychotics.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ